Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Mar 2024 for Pyxis Oncology, Inc.. Read the official filing
Filing timeline
BuySaleDarren S. Cline
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-45.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Darren S. Cline: trading record in brief
Darren S. Cline (senior executive) discloses dealings in 2 companies, chiefly Pyxis Oncology, Inc. and GW Pharmaceuticals PLC. We count 5 filings; the first trade dates from 5 May 2021 and the latest from 26 March 2024.
On the market, this insider has only ever bought: 1 purchase, €83k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants.
The latest filing, published on 28 March 2024, reports a share grant in Pyxis Oncology, Inc. The clock since the last published purchase (9 December 2021) now reads 1,774 days. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Darren S. Cline
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
35,219 shares0Common StockSEC:0000950170-24-038105:0
139,355 shares0Common StockSEC:0001209191-23-021405:0
66,831 shares0Common StockSEC:0001140361-22-012914:0
10,000 shares@ US$9.3885100.0% of flowCommon StockSEC:0000899243-21-047525:0
Canonical exit: 8 Mar 2022 (T+90)
5,556 sharesOrdinary SharesSEC:0000899243-21-018670:0
5 of 5 declarations
